Your browser doesn't support javascript.
loading
Assessment of Adverse Drug Events, Their Risk Factors, and Management Among Patients Treated for Multidrug-Resistant TB: A Prospective Cohort Study From Pakistan.
Khan, Farman Ullah; Khan, Amjad; Khan, Faiz Ullah; Hayat, Khezar; Rehman, Asim Ur; Chang, Jie; Khalid, Waseem; Noor, Sidra; Khan, Asad; Fang, Yu.
Afiliación
  • Khan FU; Department of Pharmacy Administration and Clinical Pharmacy, Xi'an Jiaotong University, Xi'an, China.
  • Khan A; Center for Drug Safety and Policy Research, Xi'an Jiaotong University, Xi'an, China.
  • Khan FU; Shaanxi Center for Health Reform and Development Research, Xi'an Jiaotong University, Xi'an, China.
  • Hayat K; Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China's Western Technological Innovation Harbor, Xi'an, China.
  • Rehman AU; Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
  • Chang J; Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
  • Khalid W; Department of Pharmacy Administration and Clinical Pharmacy, Xi'an Jiaotong University, Xi'an, China.
  • Noor S; Center for Drug Safety and Policy Research, Xi'an Jiaotong University, Xi'an, China.
  • Khan A; Shaanxi Center for Health Reform and Development Research, Xi'an Jiaotong University, Xi'an, China.
  • Fang Y; Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China's Western Technological Innovation Harbor, Xi'an, China.
Front Pharmacol ; 13: 876955, 2022.
Article en En | MEDLINE | ID: mdl-35656303

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China